跳至主要内容
临床试验/DRKS00027846
DRKS00027846已完成不适用

Patient Preferences for topical Psoriasis treatments - PsoPref

Klinik für Dermatologie Universitätsmedizin Mannheim0 个研究点目标入组 198 人开始时间: 2022年1月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
198

研究概览

简要总结

The study cohort (N = 184) considered probabilities of 50% (Relative Importance Score (RIS)=41.0) and 90% (RIS = 33.9) improvement most important, followed by risk of skin atrophy (RIS = 26.4) and treatment cost (RIS = 22.2). Treatment location (RIS = 18.9), risk of skin irritation (RIS = 16.2), treatment frequency (RIS = 13.3) and formulation (RIS = 11.0) were considered less relevant. Income, cardiovascular disease, number of visits and current topical therapy influenced treatment preferences.

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • physician-confirmed diagnosis of plaque-type psoriasis
  • written informed consent, sufficient language skills and the ability to understand the study task

排除标准

  • age < 18 years

研究者

发起方
Klinik für Dermatologie Universitätsmedizin Mannheim

相似试验